FabriziF., MartinP., PonticelliC.Hepatitis C virus infection and renal transplantation.Am J Kidney Dis2001; 38: 919–34.
2.
MartinP., CarterD., FabriziF.. Histopathological features of hepatitis C in renal transplant candidates.Transplantation2000; 69: 1479–84.
3.
HanafusaT., IchikawaY., KishikawaH.. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years.Transplantation1998; 66: 471–6.
4.
KamarN., ToupanceO., BuchlerM.. Evidence that clearance of hepatitis C virus RNA after interferon therapy in dialysis patients is sustained after renal transplantation.J Am Soc Nephrol2003; 14: 2092–8.
5.
BattyD.S., SwansonS.J., KirkA.D., AgodoaL.Y., AbbottK.C.Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival.Am J Transplant2001; 1: 179–84.
6.
ZuckerR., CiroccoR., RothD.. Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation.Transplant Proc1995; 27: 943–4.
7.
BloomR.D., RaoV., WengF., GrossmanR.A., CohenD., MangeK.C.Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.J Am Soc Nephrol2002; 13: 1374–80.
